Welcome to our dedicated page for Leonardo DRS SEC filings (Ticker: DRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Leonardo DRS, Inc. (Nasdaq: DRS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Leonardo DRS is a defense technology company headquartered in Arlington, Virginia, with common stock registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC under the symbol DRS.
Through this page, users can review Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s two primary segments, Advanced Sensing and Computing and Integrated Mission Systems, along with risk factors, contract information and financial results. Form 8-K current reports document material events such as leadership transitions, board changes, earnings releases and other significant corporate developments, including updates to executive employment agreements and conference call announcements.
Investors interested in ownership and governance details can also look for proxy statements and related filings that discuss board composition and committee responsibilities. In addition, Form 4 insider transaction reports, when available, show purchases and sales of DRS common stock by directors, officers and other insiders.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand segment performance, major contracts in areas like advanced sensing, network computing, force protection, and electric power and propulsion, and notable changes in leadership or governance. Real-time updates from EDGAR ensure that new Leonardo DRS filings, including earnings-related 8-Ks and other disclosures, are added as they become available, giving users a structured view of the company’s regulatory history and ongoing reporting obligations.
Leonardo DRS, Inc. furnished an update on its business by issuing a news release reporting financial results for the third quarter ended September 30, 2025, via an 8-K under Item 2.02.
Management plans to discuss operations and results on an earnings conference call at 9:30 a.m. Eastern Time on October 29, 2025, with a live audio webcast and supplemental presentation available through the Investor Relations website. The materials are furnished, not filed, and the news release is attached as Exhibit 99.1.
Leonardo DRS, Inc. furnished an update on its business by issuing a news release reporting financial results for the third quarter ended September 30, 2025, via an 8-K under Item 2.02.
Management plans to discuss operations and results on an earnings conference call at 9:30 a.m. Eastern Time on October 29, 2025, with a live audio webcast and supplemental presentation available through the Investor Relations website. The materials are furnished, not filed, and the news release is attached as Exhibit 99.1.
Leonardo DRS (DRS) reported an insider transaction by its EVP and COO. On October 15, 2025, the reporting person sold 8,481 shares of common stock at $43.69 per share under a Rule 10b5-1 trading plan.
Following the sale, the reporting person beneficially owns 106,007 shares directly. The trading plan was adopted on May 13, 2025.
John Baylouny, Executive Vice President and Chief Operating Officer of Leonardo DRS, reported a planned sale of company stock. On 09/17/2025 he disposed of 11,420 shares of common stock at $41.78 per share under a pre-established Rule 10b5-1 trading plan adopted May 13, 2025. Following the sale, the filing shows he beneficially owns 114,488 shares, held directly. The report was signed by attorney-in-fact Katherine Krebel on 09/18/2025. The Form 4 records a routine, prearranged insider sale rather than an open-market discretionary trade.
John Baylouny, Executive Vice President and Chief Operating Officer of Leonardo DRS, reported a planned sale of company stock. On 09/17/2025 he disposed of 11,420 shares of common stock at $41.78 per share under a pre-established Rule 10b5-1 trading plan adopted May 13, 2025. Following the sale, the filing shows he beneficially owns 114,488 shares, held directly. The report was signed by attorney-in-fact Katherine Krebel on 09/18/2025. The Form 4 records a routine, prearranged insider sale rather than an open-market discretionary trade.
An individual related to Leonardo DRS (DRS) notified the market of a proposed sale of 11,420 common shares with an aggregate market value of $477,127.60, scheduled for 09/17/2025 on NASDAQ. The shares were acquired through restricted stock vesting on 03/15/2024 and were received as compensation.
The filing also reports that the same person sold 11,375 shares on 08/20/2025 for gross proceeds of $468,308.75. The notice includes a representation that the seller does not possess undisclosed material adverse information about the issuer.
Mark Dorfman, EVP, General Counsel and Secretary of Leonardo DRS (DRS), reported insider sales under a Rule 10b5-1 trading plan. The Form 4 shows two dispositions on 09/12/2025: 4,267 shares and 8,534 shares sold at $41.65 per share, totaling 12,801 shares sold. The filing notes the trading plan was adopted on 06/13/2025. Following the reported transactions the form lists beneficial ownership positions of 47,734 shares and 39,200 shares as reported by the reporting person. The form was signed by attorney-in-fact Katherine Krebel on 09/15/2025.
Eric Salzman, a director of Leonardo DRS, Inc. (DRS), reported a sale of 4,403 shares of the company's common stock on 08/20/2025 at a price of $41.17 per share. After the sale, the filing shows he beneficially owned 11,820 shares. The Form 4 indicates the transaction was executed under a Rule 10b5-1 trading plan that the reporting person adopted on June 2, 2025. The filing was signed by an attorney-in-fact on 08/21/2025. The document records a single non-derivative sale by a director and provides no other financial results or transactions.
Leonardo DRS insider sale disclosed. John Baylouny, EVP and COO, reported a sale of 11,375 shares of Leonardo DRS (DRS) on 08/20/2025 at a reported price of $41.17 per share, leaving him with 125,908 shares beneficially owned after the transaction. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2025. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Form 144 filed for Leonardo DRS (DRS) discloses a proposed sale of 11,375 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $468,308.75. The filing lists approximately 266,123,634 shares outstanding and an approximate sale date of 08/20/2025. The shares were acquired on 03/15/2023 through restricted stock vesting and were received as compensation. The filer reports no securities sold in the past three months and includes the standard representation that the seller does not possess undisclosed material adverse information.
Leonardo DRS (DRS) filing reports a planned sale of 4,403 shares of common stock. The shares were acquired by the seller on 06/01/2024 through restricted stock vesting as compensation and are scheduled to be sold through Fidelity Brokerage Services LLC on NASDAQ on 08/20/2025. The filing shows an aggregate market value of $181,271.51 against 266,123,634 shares outstanding, and the seller attests they are not aware of any undisclosed material adverse information. The notice reports no other sales by this person in the past three months.